Charlotte Devantier Jensen.pmd - Videncenter for Allergi
Charlotte Devantier Jensen.pmd - Videncenter for Allergi
Charlotte Devantier Jensen.pmd - Videncenter for Allergi
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Contact allergy to the preservative methyldibromoglutaronitrile 3<br />
TABLE OF CONTENTS<br />
PREFACE .................................................................................................................................................................................... 2<br />
ABBREVIATIONS .................................................................................................................................................................... 4<br />
DEFINITION OF TERMS........................................................................................................................................................ 5<br />
BACKGROUND ......................................................................................................................................................................... 5<br />
ALLERGIC CONTACT DERMATITIS ................................................................................................................................................... 5<br />
Mechanisms of allergic contact dermatitis (Delayed type IV hypersensitivity) ............................................................... 6<br />
COSMETIC PRESERVATIVES .......................................................................................................................................................... 6<br />
Contact allergy to cosmetic preservatives ....................................................................................................................... 6<br />
RISK ASSESSMENT OF COSMETIC PRODUCTS .................................................................................................................................. 6<br />
THE METHYLDIBROMOGLUTARONITRILE STORY .............................................................................................................................. 7<br />
MDBGN PATCH TEST CONCENTRATION AND VEHICLE ......................................................................................... 11<br />
EXPERIMENT EXAMINING THE MDBGN PATCH TEST VEHICLE ............................................................................................................ 11<br />
AIMS OF THE THESIS ........................................................................................................................................................... 13<br />
AIM OF TRIAL I – ELICITATION STUDY OF MDBGN IN A RINSE-OFF PRODUCT.................................................................................... 13<br />
AIM OF TRIAL II – EFFECT OF SINGLE VERSUS REPEATED DAILY EXPOSURE OF MDBGN .................................................................... 13<br />
AIM OF TRIAL III – INVESTIGATION OF RE-TEST REACTIVITY BY BOTH PATCH AND USE TEST<br />
WITH MDBGN IN SENSITIZED INDIVIDUALS ..................................................................................................................................... 13<br />
METHODS ................................................................................................................................................................................ 14<br />
POPULATIONS............................................................................................................................................................................. 14<br />
PATCH TESTING .......................................................................................................................................................................... 14<br />
USE TEST .................................................................................................................................................................................. 14<br />
ELICITATION OF EXPERIMENTAL DERMATITIS ................................................................................................................................. 14<br />
EXPERIMENTAL WORK – STUDY DESIGN, RESULTS AND DISCUSSIONS .......................................................... 15<br />
TRIAL I – ELICITATION STUDY OF MDBGN IN A RINSE-OFF PRODUCT............................................................................................... 15<br />
TRIAL II – EFFECT OF SINGLE VERSUS REPEATED DAILY EXPOSURE OF MDBGN ............................................................................... 17<br />
TRIAL III – INVESTIGATION OF RE-TEST REACTIVITY BY BOTH PATCH AND USE TEST WITH MDBGN IN SENSITIZED INDIVIDUALS ........... 21<br />
GENERAL DISCUSSION AND FUTURE PERSPECTIVES ........................................................................................... 25<br />
REFERENCES ......................................................................................................................................................................... 26<br />
SUMMARY IN ENGLISH ....................................................................................................................................................... 29<br />
SUMMARY IN DANISH (RESUMÉ PÅ DANSK) ................................................................................................................ 30<br />
Forum <strong>for</strong> Nord Derm Ven Vol. 10, 2005 – Suppl. 8